Pharmacological Treatment of Acute Coronary Syndromes: Current Cardiovascular Therapy
Editat de Pablo Avanzas, Peter Clemmensenen Limba Engleză Paperback – 15 oct 2013
Preț: 335.00 lei
Preț vechi: 352.63 lei
-5% Nou
Puncte Express: 503
Preț estimativ în valută:
64.10€ • 66.93$ • 53.05£
64.10€ • 66.93$ • 53.05£
Carte tipărită la comandă
Livrare economică 05-19 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781447154235
ISBN-10: 1447154231
Pagini: 264
Ilustrații: XVI, 245 p. 24 illus., 12 illus. in color.
Dimensiuni: 127 x 203 x 14 mm
Greutate: 0.36 kg
Ediția:2014
Editura: SPRINGER LONDON
Colecția Springer
Seria Current Cardiovascular Therapy
Locul publicării:London, United Kingdom
ISBN-10: 1447154231
Pagini: 264
Ilustrații: XVI, 245 p. 24 illus., 12 illus. in color.
Dimensiuni: 127 x 203 x 14 mm
Greutate: 0.36 kg
Ediția:2014
Editura: SPRINGER LONDON
Colecția Springer
Seria Current Cardiovascular Therapy
Locul publicării:London, United Kingdom
Public țintă
Professional/practitionerCuprins
Foreword.- Preface.- Anti-ischemic Therapy.- Antiaggregant Therapy: New potent P2Y12 inhibitors.- Anticoagulation Therapy: Heparins and Factor Xa inhibitors.- Secondary prevention in ACS The role of novel oral anticoagulants.- American vs European guidelines.- Critical appraisal.- Triple therapy: Risky but sometimes necessary.- Management of bleeding complications.
Recenzii
From the reviews:
“This is a practical guide to the selection of medical therapies for acute coronary syndrome in conjunction with, or independent of, revascularization. … This book is suitable for students, advanced practice clinicians, physicians in training, and practicing clinicians interested in the management of patients with acute coronary syndromes. … a well-structured and simple guide to selection of specific pharmacological agents for acute coronary syndrome. Clinicians who care for patients with acute coronary syndrome will gain a better understanding of these therapies after reading this book.” (Saima Karim, Doody’s Book Reviews, January, 2014)
“This is a practical guide to the selection of medical therapies for acute coronary syndrome in conjunction with, or independent of, revascularization. … This book is suitable for students, advanced practice clinicians, physicians in training, and practicing clinicians interested in the management of patients with acute coronary syndromes. … a well-structured and simple guide to selection of specific pharmacological agents for acute coronary syndrome. Clinicians who care for patients with acute coronary syndrome will gain a better understanding of these therapies after reading this book.” (Saima Karim, Doody’s Book Reviews, January, 2014)
Notă biografică
Pablo Avanzas, Servicio de Cardiología, Hospital Universitario Central de Asturias, Oviedo, Spain, and Peter Clemmensen, Department of Surgery and Internal Medicine, University of Copenhagen, Denmark.
Textul de pe ultima copertă
This book updates clinicians on the most recent data regarding the medical management of patients of acute coronary syndrome (ACS), providing useful information and expert opinion on the large trials, international guidelines, and clinical practice. It reinforces the need for rapid intervention with pharmacologic therapies to treat and prevent coronary thromboembolism, and to prepare the patient for revascularization procedures, especially percutaneous coronary intervention.
Pharmacological Treatment of Acute Coronary Syndromes describes conventional treatment – including anti-ischemic, antiplatelet and anticoagulant therapy – and discusses the clinical use of newer treatment options: the potent new P2Y12 platelet receptor inhibitors with the recently recommended ticagrelor and prasugrel, and new oral anticoagulant agents showing promise for acute management and secondary prevention in ACS. Triple therapy, while not initiated in the acute setting, may impact on future surgical and medical emergencies and their management. Also covered are the various recommendations for each of the antiplatelet and anticoagulant agents in terms of patient selection, pretreatment and timing of therapy, making this book an essential read for a wide range of health professionals.
Pharmacological Treatment of Acute Coronary Syndromes describes conventional treatment – including anti-ischemic, antiplatelet and anticoagulant therapy – and discusses the clinical use of newer treatment options: the potent new P2Y12 platelet receptor inhibitors with the recently recommended ticagrelor and prasugrel, and new oral anticoagulant agents showing promise for acute management and secondary prevention in ACS. Triple therapy, while not initiated in the acute setting, may impact on future surgical and medical emergencies and their management. Also covered are the various recommendations for each of the antiplatelet and anticoagulant agents in terms of patient selection, pretreatment and timing of therapy, making this book an essential read for a wide range of health professionals.
Caracteristici
Presents highly practical information on conventional and newer treatment options for ACS Emphasis is on a just-the-facts clinical approach to the pharmalogic treatment of ACS Discusses recommendations for antiplatelet and anticoagulant agents in the treatment of ACS patients